Objective. Determine if completion lymph node dissection (CLND) is associated with improved survival in sentinel lymph node (SLN)–positive cutaneous melanoma of the head and neck (CMHN) patients.
Study Design. Retrospective analysis of large population database.
Setting. Surveillance, Epidemiology and End Results (SEER) database/multiple settings.
Subjects and Methods. Using the SEER database, the authors identified patients with SLN-positive CMHN. Clinicopathologic data and 5-year disease-specific survival (DSS) were examined for patients who underwent sentinel lymph node biopsy (SLNB) alone vs SLNB + CLND.
Results. Among 350 SLN-positive patients, 210 (60%) had SLNB + CLND, and 140 (40%) had SLNB only. Patients in the SLNB-only group were significantly older (median age 62 vs 53 years, P < .0001). The cohort as a whole did not significantly benefit from CLND; however, CLND was associated with improved DSS for a subgroup of patients age <60 years with nonulcerated tumors ≤2 mm thick (P = .03). Relative to SLNB alone, CLND did not improve survival for patients age ≥60 years or those with thicker (>2 mm) or ulcerated tumors.
Conclusions. Compared with SLNB alone, CLND does not seem to be associated with improved survival for most patients with SLN-positive CMHN. CLND likely improves survival for patients age <60 years with thin (≤2 mm) nonulcerated tumors and when there is a low risk of identifying positive non-SLNs.
GershenwaldJEAndtbackaRHPrietoVG. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26:4296-4303.
3.
KinghamTPPanageasKSAriyanCEBusamKJBradyMSCoitDG. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. Ann Surg Oncol. 2010;17:514-520.
4.
WongSLMortonDLThompsonJF. Melanoma patients with positive sentinel lymph nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol. 2006;13:809-816.
5.
BalchCMSoongSRossMI. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000;7:87-97.
6.
ChaoCWongSLEdwardsMJ. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol. 2003;10:21-26.
7.
LentschEJMcMastersKM. Sentinel lymph node biopsy for melanoma of the head and neck. Expert Rev Anticancer Ther. 2003;3:673-683.
8.
Gomez-RiveraFSantillanAMcMurphyAB. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck. 2008;30:1284-1294.
American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed.New York: Springer; 2010.
11.
QuaglinoPRiberoSOsella-AbateS. Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observation cohort study. Surg Oncol. 2011;20:259-264.
12.
SabelMSGriffithKSondakVK. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg. 2005;201:37-47.
13.
MortonDLWenDRWongJH. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
GershenwaldJEThompsonWMansfieldPF. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
16.
FincherTRMcCartyTMFisherTL. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg. 2003;186:675-681.
17.
ChaoCWongSLRossMI. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg. 2002;184:520-524.
18.
DalalKMPatelABradyMSJaquesDPCoitDG. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol. 2007;14:1934-1942.
19.
PidhoreckyILeeRJProulxG. Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann Surg Oncol. 2001;8:109-115.
20.
BalchCMSoongSJBartolucciAA. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255-266.
21.
AriyanCBradyMSGonenMBusamKCoitD. Positive nonsentinel nodestatus predicts mortality in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16:186-190.
